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Perspective
I
n a major undertaking reported 
in this issue of PLoS Medicine, a 
collaborative group co-ordinated by 
Isobel dos Santos Silva provide all but 
conclusive evidence that birth size is a 
predictor of breast cancer risk in adult 
life [1]. The researchers compiled and 
reanalysed individual participant data 
from 32 studies, comprising 22,058 
cases of breast cancer. On the basis 
of reliable data retrieved from birth 
records, they found that an increase 
of birth weight by 500 grams was 
associated with a statistically significant 
6% increase in breast cancer risk; 
whereas, controlling for birth weight, 
an increase of birth length by two 
centimetres was associated with a 9% 
increase in this risk. The relative size of 
the effects is small, but the individual 
studies driving the conclusion were of 
sound epidemiological design (cohort 
or nested case-control) and relied 
on objectively documented birth size 
parameters, allowing little room for 
selection or information bias. Now 
that the question of whether birth 
size is associated with breast cancer 
risk appears to be settled, a number 
of additional questions need to be 
addressed.
How Important Are These Findings 
in Biological and Practical Terms?
In practical terms, a 10% increase in 
breast cancer risk at the higher birth 
size category is certainly small, but 
not trivial for a common disease like 
breast cancer. Indeed, the gradient 
is in the same order of magnitude as 
that found for other common risk 
factors for breast cancer, such as age 
at menarche, age at menopause, or 
postmenopausal obesity [2]. And, 
from a biological point of view, it 
is certainly important to document 
a phenomenon that indicates the 
involvement of intrauterine processes 
in a major human cancer, as has 
already been done in animal models 
[3]. 
Can the Results Help To Explain 
Patterns in Breast Cancer Incidence 
Around the World? 
The observation of sharp ecological 
contrasts in breast cancer incidence 
around the world is one of the 
most challenging features in the 
epidemiology of the disease, and 
every hypothesis on the aetiology 
of breast cancer should be able to 
accommodate these contrasts. Breast 
cancer incidence among women of 
European descent in the Western 
world is several times higher than that 
among Chinese or Japanese women in 
Asia. The gradual elimination of this 
difference over several generations 
among Asian migrants in Western 
countries implies that genetic factors 
are not responsible for the ecological 
contrasts [2]. 
In our view, the results of the new 
collaborative group study [1] are 
compatible with the ecological patterns 
of breast cancer incidence. Newborns 
in China have lower birth weight than 
newborns of European descent in the 
United States, largely due to differences 
in maternal anthropometry that impose 
physical constraints on newborn size 
[4]. Migration from China to the US 
is associated with increased energy 
intake, leading to increased adult 
body size (including pelvic size), 
and consequently to the removal of 
constraints on birth weight. The cycle 
tends to repeat itself over consecutive 
generations of Asians migrating to the 
West and is associated with a gradual 
increase of breast cancer incidence in 
this population [4]. In the collaborative 
group study [1], controlling for adult 
height only slightly reduced the 
association of birth size with breast 
cancer risk, but, as the authors indicate, 
the adjustment was based on a small 
number of cases and misclassification 
may have hindered documentation of 
an important mediating role of adult 
height.
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Linked Research Article
This Perspective discusses the 
following new study published in PLoS
Medicine:
dos Santos Silva I, De Stavola B, 
McCormack V, Collaborative Group on 
Pre-Natal Risk Factors and Subsequent 
Risk of Breast Cancer (2008) Birth size 
and breast cancer risk: Re-analysis 
of individual participant data from 
32 studies. PLoS Med 5(9): e193. 
doi:10.1371/journal.pmed.0050193
Isobel dos Santos Silva and Bianca 
De Stavola and colleagues reanalyzed 
individual participant data from 32 
published and unpublished studies 
to obtain precise estimates of the 
association between birth size and breast 
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Can We Integrate the Study’s 
Findings into Our Current 
Understanding of the Early Stages 
in the Natural History of Breast 
Cancer?
Our current understanding of the early 
stages in the natural history of breast 
cancer is limited. Hilakivi-Clarke and 
de Assis have suggested that epigenetic 
modifications associated with large 
birth size lead to modifications in 
mammary gland development and 
increased vulnerability of epithelial 
targets for malignant transformation 
[3]. It has also been postulated 
that higher birth size is associated 
with higher levels of pregnancy 
hormones, including estrogens and 
insulin-like growth factor 1, which 
favour the generation of a higher 
number of susceptible stem cells with 
compromised genomic stability [5]. In 
this context, mammary gland mass, an 
important determinant of breast cancer 
risk, could be viewed as an adult life 
correlate of the number of mammary 
cells susceptible to transformation 
[5,6]. The group led by Chung-
Cheng Hsieh of the University of 
Massachusetts is doing important work 
in this field. This group has reported 
that high levels of insulin-like growth 
factor 1 and estriol are associated with 
larger pools of stem cells in the cord 
blood [7], and that birth size is also 
associated with the stem cell pool [8]. 
Are There Implications for the 
Primary Prevention of Breast 
Cancer?
Documentation of a positive association 
of birth size, particularly birth length, 
with breast cancer risk in adult life 
may improve prediction of disease risk, 
but does not offer much opportunity 
for prevention, particularly since 
birth size is inversely associated with 
cardiovascular risk [9]. The situation 
could change if other periods in early 
life, particularly postnatal life, were 
found to be related to adult life breast 
cancer risk. In any case, recognition 
of early life influences as critical in 
the aetiology of breast cancer helps to 
explain why several adult life primary 
prevention practices have been of 
limited effectiveness. 
Are Perinatal Exposures Important 
for Breast Cancer Only, Or Could 
They Affect Risk of Other Cancers 
As Well?
The mammary gland seems to be the 
only organ that is not fully developed 
at birth [10], which implies that 
mammary tissue–specific stem cells may 
remain in a quiescent stage for longer 
periods than tissue-specific stem cells 
for other organs. This could provide 
an explanation for why intrauterine 
factors are more important for breast 
cancer than for other cancers. It is 
reasonable, however, to expect that 
intrauterine factors could affect the 
risk of other forms of cancer, albeit to a 
lesser extent. In fact, weak birth weight 
associations have been reported for 
other cancers, although the evidence is 
still limited [11].
The intrauterine life has been 
implicated in the aetiology of breast 
cancer on the basis of theoretical 
arguments and epidemiological 
considerations [12]. However, the 
documentation of its role in breast 
cancer risk has relied on studies linking 
birth size to this risk. The Collaborative 
Group on Pre-Natal Risk Factors and 
Subsequent Risk of Breast Cancer 
has elegantly and most efficiently 
reanalysed these studies and, by 
pooling together data at the individual 
level, has provided the strongest 
evidence yet that birth size is a critical 
determinant of breast cancer risk in 
adult life.  
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